Corticosteroid formulations containing sebacate carrier
US4233295A · kind A · utility
18Cited by
4References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 1979 |
| Grant date | Nov 11, 1980 |
| Priority date | — |
| Expiry date | May 31, 1999 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Corticosteroid formulations in the form of creams, lotions or ointments are provided which are used as anti-inflammatory agents, wherein the corticosteroid, such as halcinonide (21-chloro-9-fluoro-11.beta.-hydroxy-16.alpha.,17-[(1-methylethylidene)-bi s(oxy)]pregn-4-ene-3,20-dione) is dissolved in a sebacate carrier, such as dibutyl sebacate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.